IL6 and neoplasm: However, as a bioenergetic drug, its effects on metabolic coupling markers (Cav1, MCT4) and the factors involved in tumor-fibroblast interactions (IL-6, TGFβ, and acid lactic) are not thoroughly and simultaneously examined.